Stock Detail
PHARMACYCLICS INC
Drug Manufacturers Other
PCYC @ Yahoo Finance | PCYC Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $12.00 | $12.37 | $0.09 | 0.76% | 0.00 | $11.91 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $11.79 | $11.77 | 533,957 | 824.4M | 687,282 | -17.65 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 12.65 | 12.33 | 12.05 | 11.73 | 11.45 |
Stock Profile
Pharmacyclics, Inc., a pharmaceutical company, develops products for the treatment of cancer, atherosclerosis, and other diseases. It offers Xcytrin, an anti-cancer agent designed to target cancer cells and, by disrupting cell metabolism, induce cell death through a cellular process, known as apoptosis. The company also develops Antrin angiophototherapy, which completed phase 1 clinical trails, for the treatment of atherosclerosis involving the coronary arteries of the heart. Pharmacyclics was co-founded by Richard A. Miller in 1991 and is headquartered in Sunnyvale, California.